Related Experiment Videos
Graves' disease mimicking beta-thalassemia trait
1Queen Alia Hospital (QAH), Royal Medical Services, Amman, Jordan.
Postgraduate Medical Journal
|April 1, 1994
Summary
Graves' disease can present with enlarged spleen and lymph nodes, along with anemia. Standard anti-thyroid treatment effectively resolved these hematological abnormalities.
Area of Science:
- Endocrinology
- Hematology
- Immunology
Background:
- Graves' disease is an autoimmune disorder causing hyperthyroidism.
- Hematological abnormalities are occasionally reported in Graves' disease.
- The association between Graves' disease and specific hematological findings requires further elucidation.
Observation:
- A patient with Graves' disease presented with splenomegaly (enlarged spleen) and lymphadenopathy (enlarged lymph nodes).
- The patient also exhibited microcytic hypochromic anemia and elevated hemoglobin A2 levels.
- These clinical and laboratory findings were observed concurrently with the diagnosis of Graves' disease.
Findings:
- Conventional anti-thyroid medication led to the normalization of hematological indices.
- Treatment resolved the splenomegaly, lymphadenopathy, and anemia.
- Hemoglobin A2 levels also returned to the normal range post-treatment.
Implications:
- This case highlights a potential link between Graves' disease and specific hematological manifestations.
- Effective management of hyperthyroidism may resolve associated anemia and organomegaly.
- Further research is warranted to understand the underlying mechanisms connecting autoimmune thyroid disease and these hematological changes.